M. Louis Handoko

@aayshacader Hi Aaysha, I was great meeting you! Looking forward seeing you in June. Gr. Louis

The most incredible week at @UniofOxford Such a privilege to be a part of this inaugural cohort of MSc in Clinical Trials at @Oxford_NDPH,and to finally meet and learn from these amazing people and friends from around the world! #MScClinicalTrials @Barbara_Casadei @JulePinter

After hearing about EMPEROR-PRESERVED: need a simple practical guide to initiate SGLT2 inhibitors? check: bit.ly/38lpwt6 #ESCCongress2021

An original analysis that underscores the relevance to maintain sinus rhythm in patients with underlying HFpEF by Wagemakers et al. bit.ly/3sShq4I #HFpEF #ESCCongress2021

HFpEF patients are vulnerable! Several factors identified that predict rehospitalizations in a large HFpEF-cohort by Schrutka et al. bit.ly/3jmMXZp #ESCCongress2021

High IL-6 levels associated with adverse outcome in HFpEF: a potential treatment target? by Mooney et al. bit.Ly/3DqylLh #ESCCongress

EMPEROR-PRESERVED: a true landmark trial for HFpEF! #ESCCongress2021 bit.ly/3zCaVFX